We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF

39 hedge funds and large institutions have $74.7M invested in ALPS Medical Breakthroughs ETF in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

8% more funds holding

Funds holding: 3639 (+3)

0% more capital invested

Capital invested by funds: $74.3M → $74.7M (+$356K)

1.38% less ownership

Funds ownership: 104.33%102.96% (-1.4%)

55% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 11

Holders
39
Holders Change
+3
Holders Change %
+8.33%
% of All Funds
0.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
5
Reduced
11
Closed
5
Calls
Puts
Net Calls
Net Calls Change

SBIO Hedge Fund Activity: Q3 2025 in Review

39 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q3 2025, worth a combined $74.7M — up 0.48% from $74.3M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new SBIO positions and 5 closed out — a net gain of 3 holders — while 5 added to existing stakes and 11 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $575K. The largest seller was Davenport & Co, cutting an estimated $6.88M.

  • 39 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q3 2025, up from 36 in Q2 2025.
  • Funds reported $74.7M of ALPS Medical Breakthroughs ETF stock for Q3 2025, up 0.48% quarter-over-quarter.
  • 8 funds opened new ALPS Medical Breakthroughs ETF positions in Q3 2025 and 5 closed out, a net change of +3 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q3 2025 was Virtu Financial, an estimated $575K added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q3 2025 was Davenport & Co, an estimated $6.88M sold.

Based on aggregated 13F filings for Q3 2025.